Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
Gastric cancer is one of the leading causes of cancer-related deaths worldwide. Despite the high disease prevalence, gastric cancer research has not gained much attention. Recently, genome-scale technology has made it possible to explore the characteristics of gastric cancer at the molecular level. Accordingly, gastric cancer can be classified into molecular subtypes that convey more detailed information of tumor than histopathological characteristics, and these subtypes are associated with clinical outcomes. Furthermore, this molecular knowledge helps to identify new actionable targets and develop novel therapeutic strategies. To advance the concept of precision patient care in the clinic, patient-derived xenograft (PDX) models have recently been developed. PDX models not only represent histology and genomic features, but also predict responsiveness to investigational drugs in patient tumors. Molecularly curated PDX cohorts will be instrumental in hypothesis generation, biomarker discovery, and drug screening and testing in proof-of-concept preclinical trials for precision therapy. In the era of precision medicine, molecularly tailored therapeutic strategies should be individualized for cancer patients. To improve the overall clinical outcome, a multimodal approach is indispensable for advanced cancer patients. Careful, oncological principle-based surgery, combined with a molecularly guided multidisciplinary approach, will open new horizons in surgical oncology.
Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
Y Y
YY
Choi
Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea; Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea; Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: JHCHEONG@yuhs.ac.
J-H
JH
Cheong
D000818:Animals; D004195:Disease Models, Animal; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D006801:Humans; D058990:Molecular Targeted Therapy; D066230:Patient-Specific Modeling; D057285:Precision Medicine; D011379:Prognosis; D013274:Stomach Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*
Biology; Classification; Gastric cancer; Patient-derived xenograft; Precision medicine; Preclinical model